Multigene Panel Testing Outcomes in Patients with Uveal Melanoma: Implementation of National Guidelines
Preprint
Abstract
This study aimed to evaluate the outcome of germline clinical genetic testing in uveal melanoma (UM) patients who met the National Comprehensive Cancer Network (NCCN) guidelines for genetic testing. A retrospective chart review was conducted on UM patients seen in The Ohio State University Cancer Genetics Clinic between 5/1/2021-9/19/2025. Seventy individuals underwent clinical genetic testing, primarily via large multi-gene panels. Ten UM patients, including two related individuals, had pathogenic or likely pathogenic (P/LP) variants in known cancer genes ( BAP1, BRCA1, BRCA2, MBD4, MUTYH, POT1, XRCC2) . Among unrelated individuals, the positive rate was12.9% (8/70). Excluding carrier genes, the rate was10% (7/70) Eight patients would have been missed if only tested for BAP1 per ASCO 2024 recommendations. There was no association between tumor size, stage and germline P/LP variants. In summary, NCCN guidelines are useful in the prioritization of UM patients for genetic testing. Additionally, large panel testing, rather than BAP1 single gene testing, is recommended.Keywords
This publication has 25 references indexed in Scilit:
- Uveal Melanoma and the Lynch Syndrome Tumor SpectrumJAMA Ophthalmology, 2025
- Hereditary predisposition to uveal melanoma2019
- Inherited variants in XRCC2 and the risk of breast cancerBreast Cancer Research and Treatment, 2019
- Fumarate hydrataseFHc.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinomaHuman Mutation, 2019
- Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumabImmunogenetics, 2019
- Clinical Characteristics of Uveal Melanoma in Patients With GermlineBAP1MutationsJAMA Ophthalmology, 2015
- Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarianCancer, 2014
- Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutationsFamilial Cancer, 2011
- Cancer family history characterization in an unselected cohort of 121 patients with uveal melanomaFamilial Cancer, 2010
- CDKN2A as a uveal and cutaneous melanoma susceptibility geneGenes, Chromosomes and Cancer, 2003